¿¬¼ö°­ÁÂ
Á¦1ȸ ¾È¿°Áõ ½ÉÆ÷Áö¾ö (Çѱ¹Æ÷µµ¸·ÇÐȸ Çѱ¹¿Ü¾ÈºÎÇÐȸ °øµ¿ÁÖ°ü) : 2022-11-13
Á¦1ȸ ¾È¿°Áõ ½ÉÆ÷Áö¾ö (Çѱ¹Æ÷µµ¸·ÇÐȸ Çѱ¹¿Ü¾ÈºÎÇÐȸ °øµ¿ÁÖ°ü) : 2022-11-13
±³À°ÀÏÀÚ : 2022-11-13
±³À°Àå¼Ò : ¼­¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ  
±³À°ÁÖÁ¦ : (¿Â-¿ÀÇÁº´Çà) Á¦1ȸ ¾È¿°Áõ ½ÉÆ÷Áö¾ö (Çѱ¹Æ÷µµ¸·ÇÐȸ Çѱ¹¿Ü¾ÈºÎÇÐȸ °øµ¿ÁÖ°ü)
ÁÖÃÖ±â°ü : ´ëÇѾȰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹Æ÷µµ¸·ÇÐȸ  
´ã´çÀÚ : Á¶À翵
¿¬¶ôó : 02-6403-4300  
À̸ÞÀÏ : jyjomtl@naver.com      
±³À°Á¾·ù : ¾È°ú      
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 25ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í Á¤È¸¿ø Àü¹®ÀÇ : »çÀüµî·Ï ¹«·á, ÇöÀåµî·Ï 40,000¿ø  ºñȸ¿ø Àü¹®ÀÇ : »çÀüµî·Ï 30,000¿ø, ÇöÀåµî·Ï 40,000¿ø  Àü°øÀÇ : »çÀüµî·Ï 20,000¿ø, ÇöÀåµî·Ï 30,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 08:50~08:55 °³È¸»ç  ±è¼±¿õ(¿¬¼¼´ë) 
±âŸ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 08:55~09:00 Çѱ¹Æ÷µµ¸·ÇÐȸ Çѱ¹¿Ü¾ÈºÎÇÐȸ ȸÀå´Ô ÀÎ»ç ¸»¾¸  ÇÔµ·ÀÏ ÀÌÇü±Ù(¼º±Õ°ü´ë ¿¬¼¼´ë) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 09:00~09:10 A to Z essentials for ocular immunology  ÃÖÇõÁø(¼­¿ï´ë) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 09:10~09:20 Innovative application of regenerative medicine for anterior segment inflammation management  ³ª°æ¼±(°¡Å縯´ë) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 09:20~09:30 Innovations in drug delivery and novel therapeutics for posterior segment inflammation management  ¼ÛÁöÈÆ(¾ÆÁÖ´ë) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 09:30~09:40 Ocular fluid biopsy in the omics era: anterior  Áö¿ë¿ì(¿¬¼¼´ë) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 09:40~09:50 Ocular fluid biopsy in the omics era: posterior  ½ÅÁÖ¿µ(¼­¿ï´ë) 
Åä·Ð 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 09:50~10:05 Discussion  -(-) 
È޽Ġ11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 10:05~10:20 Break  -(-) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 10:20~10:30 Viral inflammatory diseases: anterior aspects  ±è¼ºÀç(°æ»ó´ë) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 10:30~10:40 Viral inflammatory diseases: posterior aspects  Áö¿µ¼®(Àü³²´ë) 
Åä·Ð 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 10:40~10:45 Discussion  -(-) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 10:45~10:55 Conjunctival melanoma  ±è¼±¿õ(¿¬¼¼´ë) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 10:55~11:05 Uveal melanoma  À̽±Ô(¿¬¼¼´ë) 
Åä·Ð 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 11:05~11:10 Discussion  -(-) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 11:10~11:20 Uveitis: anterior approach  ¹Úö¿ë(µ¿±¹´ë) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 11:20~11:30 Uveitis: posterior approach  À̹̿¬(°¡Å縯´ë) 
Åä·Ð 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 11:30~11:35 Discussion  -(-) 
È޽Ġ11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 11:35~11:50 Break  -(-) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 11:50~12:20 Demystifying Viral Anterior Uveitis  Soon Phaik Chee(Singapore National Eye Centre) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 12:20~12:50 Treatment for Intermediate, Posterior and Panuveitis  Jennifer Elizabeth Thorne(Johns Hopkins University) 
Åä·Ð 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 12:50~13:00 Discussion  -(-) 
½Ä»ç 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 13:00~14:00 Lunch  -(-) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:00~14:10 Systemic work-up in uveitis patients; is it always necessary?  ½ÅÁÖ¿¬(¿¬¼¼´ë) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:10~14:20 Management of uveitis before and after cataract surgery  Àü·ç¹Î(ÀÌÈ­¿©´ë) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:20~14:30 Surgical management of uveitis  Á¶¿µÁØ(Ãæ³²´ë) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:30~14:40 TASS vs endophthalmitis  ±èÀç¿ë(¿ï»ê´ë) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:40~14:50 How to approach inflammatory diseases in children  ÀÌÁÖ¿ë(¿ï»ê´ë) 
Åä·Ð 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:50~15:05 Discussion  -(-) 
È޽Ġ11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:05~15:20 Break  -(-) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:20~15:30 Outbreak of fungal endophthalmitis: the aftermath  ±è¼º¿ì(°í·Á´ë) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:30~15:40 The application of en face OCT imaging in uveitis  ¸¶´ëÁß(ÇѸ²´ë) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:40~15:50 Prevalence of HCQ Retinopathy and Recommendation on Screening in Rheumatic Patients with Dry Eye Symptoms  Á¤Áö¿ø(ÀÎÇÏ´ë) 
±³À°½Ã°£ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:50~16:00 The alternative faces of macrophage in the ocular surface  ±è°æ¿ì(Áß¾Ó´ë) 
Åä·Ð 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 16:00~16:10 Discussion  -(-) 
±âŸ 11-13 ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 16:10~16:15 Æóȸ»ç  À̽±Ô(¿¬¼¼´ë) 
  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ 16th Vascular Ultrasound Seoul Update 2023 Symposium (2ÀÏÂ÷) : 2024-04-21

±³À°ÀÏÀÚ : 2024-04-21 ±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø ÁöÇÏ 1Ãþ ´ë°­´ç ±³À°ÁÖÁ¦ : 16th Vascular Ultrasound Seoul Update 2023

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,199 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­Á : 2024-03-09

±³À°ÀÏÀÚ : 2024-03-09 ±³À°Àå¼Ò : (¿Â¶óÀÎ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ½Å¼ººóÇ÷¿¬

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,222 , ´ñ±Û¼ö : 0

[Àü³²] 2024³â ´ëÇѸ鿪ÇÐȸ 50Áֳ⠱â³ä Ãá°èÇмú´ëȸ 1ÀÏÂ÷ : 2024-04-11

±³À°ÀÏÀÚ : 2024-04-11 ±³À°Àå¼Ò : ¿©¼ö ¿¢½ºÆ÷ ÄÁº¥¼Ç¼¾ÅÍ ¿¢½ºÆ÷Ȧ ±³À°ÁÖÁ¦ : 2024³â ´ëÇѸ鿪ÇÐȸ 50Áֳ⠱â³ä Ãá°èÇмú´ëȸ 1ÀÏÂ÷ÁÖÃÖ±â°ü : ´ëÇѸ鿪ÇÐȸ ´ã´çÀÚ

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,095 , ´ñ±Û¼ö : 0

[¼­¿ï] ¼¼ºê¶õ½ºº´¿ø 2018 ¼¼¸ñȸ Çмú´ëȸ : 2018-11-10

±³À°ÀÏÀÚ : 2018-11-10 ±³À°Àå¼Ò : °­³² ¼¼ºê¶õ½ºº´¿ø ´ë°­´ç ±³À°ÁÖÁ¦ : 2018 ¼¼¸ñȸ Çмú´ëȸ ÁÖÃÖ±â°ü : ¼¼ºê¶õ½ºº´¿ø ½ÃÇà±â°ü(ÁöºÎ/°ú) : ¾È°ú ´ã´çÀÚ : ¹Ú

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,955 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇÑÁ¶Çöº´ÇÐȸ Treatment and management of symptoms and physical health in schizophrenia : 2024-04-2..

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ±³À°ÁÖÁ¦ : Treatment and management of symptoms and physical health i

Ãßõ¼ö : 0 , Á¶È¸¼ö : 4,951 , ´ñ±Û¼ö : 0